Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Sharps Technology, Inc. (STSS)

Compare
0.0423
-0.1104
(-72.30%)
At close: March 28 at 4:00:01 PM EDT
0.0370
-0.01
(-12.53%)
Pre-Market: 6:24:09 AM EDT
Loading Chart for STSS
  • Previous Close 0.1527
  • Open 0.1500
  • Bid 0.0380 x 200
  • Ask 0.0430 x 1100
  • Day's Range 0.0388 - 0.1500
  • 52 Week Range 0.0388 - 18.1500
  • Volume 214,434,003
  • Avg. Volume 19,947,298
  • Market Cap (intraday) 468,599
  • Beta (5Y Monthly) 1.46
  • PE Ratio (TTM) --
  • EPS (TTM) -8.2400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

sharpstechnology.com

57

Full Time Employees

December 31

Fiscal Year Ends

Recent News: STSS

View More

Performance Overview: STSS

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

STSS
97.95%
S&P 500 (^GSPC)
5.11%

1-Year Return

STSS
99.44%
S&P 500 (^GSPC)
6.22%

3-Year Return

STSS
99.93%
S&P 500 (^GSPC)
21.97%

5-Year Return

STSS
99.93%
S&P 500 (^GSPC)
119.59%

Compare To: STSS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: STSS

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    468.60k

  • Enterprise Value

    329.54k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.07

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -42.43%

  • Return on Equity (ttm)

    -92.06%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -7.87M

  • Diluted EPS (ttm)

    -8.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.47M

  • Total Debt/Equity (mrq)

    35.88%

  • Levered Free Cash Flow (ttm)

    -6.7M

Research Analysis: STSS

View More

Company Insights: STSS

Research Reports: STSS

View More

People Also Watch